Synthetic MMP inhibitors could suppress lipid accumulation in human mesenchymal stem cells and adipogenesis (Bosco et al., 2017), suggesting a possible protective function of MT1-MMP in the development of obesity. This evidence concerns the gene MMP14 and obesity disorder.